Arvinas, Inc. Common Stock (ARVN) Stock
Key stats
- Market cap
- $452.50M
- Price / Earnings ratio
- -47.7x
- EPS (TTM)
- -$0.07
- Volume
- Loading
- 52-week high
- $14.51
- 52-week low
- $6.33
Source: third-party data provider, as of November 13, 2026
Compare with ARVN
Recent news

What Arvinas (ARVN) Said on Its Q3 Earnings Call
What Arvinas (ARVN) Said on Its Q3 Earnings Call
ARVN

Arvinas, Inc. (ARVN) Reports Q3 Loss, Misses Revenue Estimates
Arvinas, Inc. (ARVN) Reports Q3 Loss, Misses Revenue Estimates
ARVN

Reasons Why Investors Should Consider Betting on Arvinas Stock
Reasons Why Investors Should Consider Betting on Arvinas Stock
ARVN

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know
Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know
ARVN
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 43.56
- MACD 12/26/9
- -0.24
- EMA 9 of MACD
- -0.20
- MACD histogram
- -0.04
- SMA 50
- $7.72
- Price below SMA 50
- EMA 50
- $7.62
- Price below EMA 50
- SMA 200
- $9.46
- Price below SMA 200
- EMA 200
- $9.40
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

What Arvinas (ARVN) Said on Its Q3 Earnings Call
What Arvinas (ARVN) Said on Its Q3 Earnings Call
ARVN

Arvinas, Inc. (ARVN) Reports Q3 Loss, Misses Revenue Estimates
Arvinas, Inc. (ARVN) Reports Q3 Loss, Misses Revenue Estimates
ARVN

Reasons Why Investors Should Consider Betting on Arvinas Stock
Reasons Why Investors Should Consider Betting on Arvinas Stock
ARVN

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know
Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know
ARVN

Arvinas Q2 Earnings Call Highlights
Arvinas Q2 Earnings Call Highlights
ARVN

Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates
Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates
ARVN

Arvinas Sharpens Pipeline Focus After First PROTAC Approval, Eyes Key Trial Data
Arvinas Sharpens Pipeline Focus After First PROTAC Approval, Eyes Key Trial Data
ARVN

RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside?
RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside?
ARVN

Arvinas Q1 Earnings Call Highlights
Arvinas Q1 Earnings Call Highlights
ARVN

Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates
Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates
ARVN
News tone: automated (AI) classification of the article's content, not a price prediction.
About Arvinas, Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Randy Teel Ph.D. | CEO, President & Director | 1980 |
| Mr. Andrew R. Saik | CFO & Treasurer | 1969 |
| Ms. Angela M. Cacace Ph.D. | Chief Scientific Officer | 1968 |
| Mr. David K. Loomis M.B.A. | VP & Chief Accounting Officer | 1974 |
| Mr. Jeff Boyle | Vice President of Investor Relations | — |
| Mr. Jared M. Freedberg J.D. | General Counsel & Corporate Secretary | 1969 |
| Mr. Steve Weiss | Senior VP & Chief Human Resources Officer | 1970 |
| Mr. Paul McInulty | Senior Vice President of Regulatory Affairs | — |
| Ms. Kelly Page | Senior VP & Global Head of Oncology Strategy and Program Leadership | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 43.56
- MACD 12/26/9
- -0.24
- EMA 9 of MACD
- -0.20
- MACD histogram
- -0.04
- SMA 50
- $7.72
- Price below SMA 50
- EMA 50
- $7.62
- Price below EMA 50
- SMA 200
- $9.46
- Price below SMA 200
- EMA 200
- $9.40
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $13.00
- Average
- $13.00
- High
- $13.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -8.9 | +8.3 | ||||||||||
| 2022 | -12.4 | -7.5 | +2.4 | -21.5 | -25.6 | +2.8 | +24.7 | -16.0 | +2.1 | +16.1 | -20.0 | -13.9 |
| 2023 | -1.8 | -8.4 | -10.6 | -8.1 | -19.3 | +14.2 | -1.8 | +13.5 | -29.5 | -14.4 | +37.5 | +74.4 |
| 2024 | +0.0 | +0.7 | -12.7 | -21.4 | +2.0 | -4.6 | +5.9 | -2.3 | -3.4 | +6.2 | -0.7 | -25.5 |
| 2025 | -6.8 | +3.5 | -56.7 | +36.8 | -0.4 | +0.4 | -2.5 | +4.2 | +7.8 | +11.1 | +29.5 | +0.4 |
| 2026 | +16.7 | -4.0 | -20.8 | -12.6 | -14.6 | -3.1 | -2.1 | +14.1 | -16.6 | +5.8 | -8.1 |



